MARKER THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
MARKER THERAPEUTICS, INC. (MRKR) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 6.82 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14
- MARKER THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 6.79M shares, a 17.98% increase year-over-year.
- MARKER THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 5.76M shares, a 801.24% increase year-over-year.
- MARKER THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-09-30 was 596.00K shares, a 77.49% decline year-over-year.
- MARKER THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 639.00K shares, a 79.68% decline year-over-year.
- MARKER THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 6.79M shares, a 23.37% decline from fiscal 2024.
- MARKER THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 8.87M shares, a 1101.41% increase from fiscal 2023.
- MARKER THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 738.00K shares, a 73.01% decline from fiscal 2022.
- MARKER THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.73M shares, a 0.64% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 6.82M shares 10-Q · filed 2026-08-14 | |||||||
| 2026-03-31 | 6.79M shares 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | 6.79M shares 10-K · filed 2026-03-18 | |||||||
| 2025-09-30 | 5.73M shares 10-Q · filed 2025-11-13 | |||||||
| 2025-06-30 | 5.74M shares 10-Q · filed 2026-08-14 | 5.74M shares 10-Q · filed 2025-08-14 | ||||||
| 2025-03-31 | 5.76M shares 10-Q · filed 2026-05-15 | 5.76M shares 10-Q · filed 2025-05-15 | ||||||
| 2024-12-31 | 8.87M shares 10-K · filed 2026-03-18 | 8.87M shares 10-K · filed 2025-03-31 | ||||||
| 2024-09-30 | 596.00K shares 10-Q · filed 2024-11-14 | 596.00K shares 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | 601.00K shares 10-Q · filed 2025-08-14 | |||||||
| 2024-03-31 | 639.00K shares 10-Q · filed 2025-05-15 | |||||||
| 2023-12-31 | 738.00K shares 10-K · filed 2025-03-31 | |||||||
| 2023-09-30 | 2.65M shares 10-Q · filed 2024-11-14 | 2.60M shares 10-Q · filed 2024-11-14 | ||||||
| 2023-06-30 | 2.99M shares 10-Q · filed 2023-08-14 | 2.99M shares 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | 3.15M shares 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | 2.73M shares 10-K · filed 2024-03-26 | |||||||
| 2022-09-30 | 2.84M shares 10-Q · filed 2023-11-09 | 2.84M shares 10-Q · filed 2023-11-09 | 28.44M shares 10-Q · filed 2022-11-10 | |||||
| 2022-06-30 | 2.84M shares 10-Q · filed 2023-08-14 | 2.84M shares 10-Q · filed 2023-08-14 | 28.44M shares 10-Q · filed 2022-08-11 | |||||
| 2022-03-31 | 2.92M shares 10-Q · filed 2023-05-15 | 29.22M shares 10-Q · filed 2022-05-13 | ||||||
| 2021-12-31 | 2.75M shares 10-K · filed 2023-03-22 | 27.52M shares 10-K · filed 2022-03-17 | ||||||
| 2021-09-30 | 27.37M shares 10-Q · filed 2022-11-10 | |||||||
| 2021-06-30 | 28.29M shares 10-Q · filed 2022-08-11 | |||||||
| 2021-03-31 | 28.32M shares 10-Q · filed 2021-05-12 | |||||||
| 2020-12-31 | 26.83M shares 10-K · filed 2022-03-17 | |||||||
| 2020-09-30 | 26.85M shares 10-Q · filed 2021-11-10 | |||||||
| 2020-06-30 | 27.22M shares 10-Q · filed 2021-08-10 | |||||||
| 2020-03-31 | 27.67M shares 10-Q · filed 2021-05-12 | |||||||
| 2019-12-31 | 27.65M shares 10-K · filed 2021-03-09 | |||||||
| 2019-09-30 | 27.33M shares 10-Q · filed 2020-11-09 | |||||||
| 2019-06-30 | 27.57M shares 10-Q · filed 2020-08-10 | |||||||
| 2019-03-31 | 27.54M shares 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | 27.14M shares 10-K · filed 2020-03-12 | |||||||
| 2018-09-30 | 5.09M shares 10-Q · filed 2019-11-12 | |||||||
| 2018-06-30 | 5.31M shares 10-Q · filed 2019-08-09 | |||||||
| 2018-03-31 | 6.96M shares 10-Q · filed 2019-05-10 | |||||||
| 2017-12-31 | 7.01M shares 10-K · filed 2019-03-15 | |||||||
| 2017-09-30 | 6.98M shares 10-Q · filed 2018-11-13 | |||||||
| 2017-06-30 | 7.00M shares 10-Q · filed 2017-08-07 | 7.00M shares 10-Q · filed 2018-08-09 | 7.00M shares 10-Q · filed 2017-08-07 | |||||
| 2017-03-31 | 5.48M shares 10-Q · filed 2018-05-15 | 5.48M shares 10-Q · filed 2017-05-05 | ||||||
| 2016-12-31 | 5.49M shares 10-K · filed 2018-03-23 | |||||||
| 2016-09-30 | 5.49M shares 10-Q · filed 2017-11-14 | |||||||
| 2016-06-30 | 2.75M shares 10-Q · filed 2017-08-07 | 32.96M shares 10-Q · filed 2016-08-15 | 2.58M shares 10-Q · filed 2017-08-07 | 30.94M shares 10-Q · filed 2016-08-15 | ||||
| 2016-03-31 | 4.64M shares 10-Q · filed 2017-05-05 | 55.67M shares 10-Q · filed 2016-05-16 | ||||||
| 2015-12-31 | 4.64M shares 10-K · filed 2017-03-14 | 55.69M shares 10-K · filed 2016-04-14 | ||||||
| 2015-09-30 | 5.00M shares 10-Q · filed 2016-11-04 | |||||||
| 2015-06-30 | 84.86M shares 10-Q · filed 2016-08-15 | 84.86M shares 10-Q · filed 2016-08-15 | 84.85M shares 10-Q · filed 2015-08-14 | |||||
| 2015-03-31 | 64.81M shares 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | 2.72M shares 10-K · filed 2016-04-14 | |||||||
| 2014-06-30 | 306.00K shares 10-Q/A · filed 2016-04-14 | |||||||
| 2014-03-31 | 330.00K shares 10-Q/A · filed 2016-04-14 | |||||||
| 2013-12-31 | 953.64K shares 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |